Kirby Lester pill counter sales rise after hydrocodone reclassification
Kirby Lester reported a spike in sales of its KL1 and KL1Plus tablet counters in October following the Drug Enforcement Agency’s reclassification of hydrocodone combination products to Schedule II. Kirby Lester KL1 (left) and KL1Plus tablet counters.